In Brief
This article was originally published in The Tan Sheet
Executive Summary
Perrigo to launch Delysm equivalent; Ways and Means clears FSA use for OTCs; user fee bills go to conference committee; FDA uncovers more spiked supplements; EMA lists spontaneous side effects; more news In Brief.
You may also be interested in...
DMAA Warnings Shed Light On FDA NDI Enforcement
FDA’s warning letters to 10 marketers of DMAA-containing products might have a silver lining for the supplement industry as they suggest the agency may be flexible on its controversial interpretation of some provisions in the new dietary ingredient notification requirement.
HELP Committee Leaders Add Voice To Doubts About New User Fees
HELP Chairman Harkin and ranking member Enzi say potential riders added to the FDA user fee bill could slow down passage and add more work for agency staff. The senators’ concern follows House appropriators’ doubts as obstacles to approval for new food safety user fees.
Coalition Pushes Congress On OTC Purchases With Health Savings Accounts
The Health Choices Coalition sent letters urging House and Senate members to support legislation that would strike the health care reform law requirement that consumers obtain a prescription in order to purchase OTCs with a pre-tax savings account.